{"entity":{"type":"insider","cik":"0001255349","url":"/insider/0001255349","json_url":"/insider/0001255349.json","name":"RYAN UNA S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":4,"first":"2004-08-04","last":"2020-03-12","span_basis":"filed_date"},"name_variants":[{"name":"RYAN UNA S","source":"filing","n_filings":4,"first_seen":"2004-08-04","last_seen":"2020-03-12"}],"transactions":[{"id":2335117,"accession":"0001209191-20-018550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-018550","line_url":"/filing/0001209191-20-018550#line-1","is_derivative":false,"issuer_cik":"0001255349","issuer_name":"Cortexyme, Inc.","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001255349","owner_cik":"0001255349","owner_name":"RYAN UNA S","owner_display_name":"RYAN UNA S","owner_url":"/insider/0001255349","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2875.0,"shares_display":"2,875","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":48875.0,"total_display":"48,875.00","total_whole":"48,875","shares_owned_after":2875.0,"shares_owned_after_display":"2,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2020-03-12","scope":"insider"},{"id":2494994,"accession":"0001179110-12-008843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-008843","line_url":"/filing/0001179110-12-008843#line-1","is_derivative":false,"issuer_cik":"0001065087","issuer_name":"ALBANY MOLECULAR RESEARCH INC","issuer_ticker":"AMRI","issuer_name_source":null,"issuer_url":"/issuer/0001065087","owner_cik":"0001255349","owner_name":"RYAN UNA S","owner_display_name":"RYAN UNA S","owner_url":"/insider/0001255349","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":562.0,"total_display":"562.00","total_whole":"562","shares_owned_after":14017.0,"shares_owned_after_display":"14,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-22","filed_date":"2012-05-23","scope":"insider"},{"id":3736493,"accession":"0001179110-06-016874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-06-016874","line_url":"/filing/0001179110-06-016874#line-1","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"AVANT IMMUNOTHERAPEUTICS INC","issuer_ticker":"AVAN","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255349","owner_name":"RYAN UNA S","owner_display_name":"RYAN UNA S","owner_url":"/insider/0001255349","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30300.0,"shares_display":"30,300","price_per_share":1.355,"price_display":"1.36","price_state":"stated","total_value":41056.5,"total_display":"41,056.50","total_whole":"41,057","shares_owned_after":898713.0,"shares_owned_after_display":"898,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-16","filed_date":"2006-08-16","scope":"insider"},{"id":464250,"accession":"0001179110-04-015834","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-04-015834","line_url":"/filing/0001179110-04-015834","is_derivative":false,"issuer_cik":"0000744218","issuer_name":"AVANT IMMUNOTHERAPEUTICS INC","issuer_ticker":"AVAN","issuer_name_source":null,"issuer_url":"/issuer/0000744218","owner_cik":"0001255349","owner_name":"RYAN UNA S","owner_display_name":"RYAN UNA S","owner_url":"/insider/0001255349","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.870873,"price_display":"1.87","price_state":"stated","total_value":18708.73,"total_display":"18,708.73","total_whole":"18,709","shares_owned_after":466913.0,"shares_owned_after_display":"466,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-03","filed_date":"2004-08-04","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001662774","name":"Cortexyme, Inc.","url":"/issuer/0001662774","role":"Director","n_filings":1,"first_seen":"2020-03-12","last_seen":"2020-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001065087","name":"ALBANY MOLECULAR RESEARCH INC","url":"/issuer/0001065087","role":"Director","n_filings":1,"first_seen":"2012-05-23","last_seen":"2012-05-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000744218","name":"AVANT IMMUNOTHERAPEUTICS INC","url":"/issuer/0000744218","role":"Director, Officer (President & CEO)","n_filings":2,"first_seen":"2004-08-04","last_seen":"2006-08-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001255349","retrieved_at":"2026-08-22T11:04:53+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}